Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063841770> ?p ?o ?g. }
- W2063841770 endingPage "1097" @default.
- W2063841770 startingPage "1092" @default.
- W2063841770 abstract "Objectives Transformation of normal epithelium into cancer cells involves epigenetic and genetic changes and modifications in nuclear structure and tissue architecture. To evaluate nuclear morphometric alterations and clinicopathologic features for organ- vs nonorgan-confined prostate carcinoma (PCa) prediction. Methods Of 557 prospectively enrolled patients, 370 had complete information and sufficient tumor area for all evaluated parameters (281 organ-confined and 89 nonorgan-confined PCa cases). Digital images of Feulgen DNA-stained nuclei were captured from biopsies using the AutoCyte imaging system, and the nuclear morphometric alterations were calculated. Logistic regression analysis with bootstrap resampling was used to determine the factors important for differentiation of the 2 groups and to generate models for organ- vs nonorgan-confined PCa prediction. Results Several nuclear morphometric features were significantly altered and could differentiate organ- and nonorgan-confined disease. DNA ploidy was the most important factor among the significant nuclear morphometric features and was the second most important factor for organ- vs nonorgan-confined PCa prediction when considered with total prostate-specific antigen (PSA), complexed PSA, free/total PSA, biopsy Gleason score, and clinical stage. The combination of DNA ploidy with clinical stage, total PSA, and biopsy Gleason score showed an improvement of 1.5% in the area under the receiver operator characteristic curves compared with the combination of clinical stage, total PSA, and biopsy Gleason (73.97% vs 72.43%). The use of DNA ploidy in lieu of the biopsy Gleason score in each preoperative model evaluated resulted in equivalent or improved organ- vs nonorgan-confined PCa prediction. Conclusions The results of our study have shown that DNA ploidy can serve as a surrogate biomarker that has the potential to replace biopsy Gleason scores for organ- vs nonorgan-confined PCa prediction. Transformation of normal epithelium into cancer cells involves epigenetic and genetic changes and modifications in nuclear structure and tissue architecture. To evaluate nuclear morphometric alterations and clinicopathologic features for organ- vs nonorgan-confined prostate carcinoma (PCa) prediction. Of 557 prospectively enrolled patients, 370 had complete information and sufficient tumor area for all evaluated parameters (281 organ-confined and 89 nonorgan-confined PCa cases). Digital images of Feulgen DNA-stained nuclei were captured from biopsies using the AutoCyte imaging system, and the nuclear morphometric alterations were calculated. Logistic regression analysis with bootstrap resampling was used to determine the factors important for differentiation of the 2 groups and to generate models for organ- vs nonorgan-confined PCa prediction. Several nuclear morphometric features were significantly altered and could differentiate organ- and nonorgan-confined disease. DNA ploidy was the most important factor among the significant nuclear morphometric features and was the second most important factor for organ- vs nonorgan-confined PCa prediction when considered with total prostate-specific antigen (PSA), complexed PSA, free/total PSA, biopsy Gleason score, and clinical stage. The combination of DNA ploidy with clinical stage, total PSA, and biopsy Gleason score showed an improvement of 1.5% in the area under the receiver operator characteristic curves compared with the combination of clinical stage, total PSA, and biopsy Gleason (73.97% vs 72.43%). The use of DNA ploidy in lieu of the biopsy Gleason score in each preoperative model evaluated resulted in equivalent or improved organ- vs nonorgan-confined PCa prediction. The results of our study have shown that DNA ploidy can serve as a surrogate biomarker that has the potential to replace biopsy Gleason scores for organ- vs nonorgan-confined PCa prediction." @default.
- W2063841770 created "2016-06-24" @default.
- W2063841770 creator A5032242615 @default.
- W2063841770 creator A5033793895 @default.
- W2063841770 creator A5035137850 @default.
- W2063841770 creator A5062227791 @default.
- W2063841770 creator A5063449536 @default.
- W2063841770 creator A5073431093 @default.
- W2063841770 creator A5085439390 @default.
- W2063841770 date "2009-05-01" @default.
- W2063841770 modified "2023-09-30" @default.
- W2063841770 title "DNA Ploidy as Surrogate for Biopsy Gleason Score for Preoperative Organ Versus Nonorgan-confined Prostate Cancer Prediction" @default.
- W2063841770 cites W1512056949 @default.
- W2063841770 cites W1975289552 @default.
- W2063841770 cites W1989522197 @default.
- W2063841770 cites W1995723227 @default.
- W2063841770 cites W2007133171 @default.
- W2063841770 cites W2011120797 @default.
- W2063841770 cites W2015315310 @default.
- W2063841770 cites W2022025102 @default.
- W2063841770 cites W2041141295 @default.
- W2063841770 cites W2042904794 @default.
- W2063841770 cites W2043103956 @default.
- W2063841770 cites W2052072429 @default.
- W2063841770 cites W2056738508 @default.
- W2063841770 cites W2060596218 @default.
- W2063841770 cites W2088784586 @default.
- W2063841770 cites W2115318189 @default.
- W2063841770 cites W2125999800 @default.
- W2063841770 cites W2129020851 @default.
- W2063841770 cites W2143528834 @default.
- W2063841770 cites W2257158940 @default.
- W2063841770 cites W2401708736 @default.
- W2063841770 cites W2410926875 @default.
- W2063841770 cites W2412550293 @default.
- W2063841770 cites W4248667616 @default.
- W2063841770 doi "https://doi.org/10.1016/j.urology.2008.09.060" @default.
- W2063841770 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2697847" @default.
- W2063841770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19193410" @default.
- W2063841770 hasPublicationYear "2009" @default.
- W2063841770 type Work @default.
- W2063841770 sameAs 2063841770 @default.
- W2063841770 citedByCount "13" @default.
- W2063841770 countsByYear W20638417702012 @default.
- W2063841770 countsByYear W20638417702013 @default.
- W2063841770 countsByYear W20638417702014 @default.
- W2063841770 countsByYear W20638417702015 @default.
- W2063841770 countsByYear W20638417702017 @default.
- W2063841770 countsByYear W20638417702020 @default.
- W2063841770 countsByYear W20638417702023 @default.
- W2063841770 crossrefType "journal-article" @default.
- W2063841770 hasAuthorship W2063841770A5032242615 @default.
- W2063841770 hasAuthorship W2063841770A5033793895 @default.
- W2063841770 hasAuthorship W2063841770A5035137850 @default.
- W2063841770 hasAuthorship W2063841770A5062227791 @default.
- W2063841770 hasAuthorship W2063841770A5063449536 @default.
- W2063841770 hasAuthorship W2063841770A5073431093 @default.
- W2063841770 hasAuthorship W2063841770A5085439390 @default.
- W2063841770 hasBestOaLocation W20638417702 @default.
- W2063841770 hasConcept C121608353 @default.
- W2063841770 hasConcept C126322002 @default.
- W2063841770 hasConcept C142724271 @default.
- W2063841770 hasConcept C146357865 @default.
- W2063841770 hasConcept C151730666 @default.
- W2063841770 hasConcept C2775934546 @default.
- W2063841770 hasConcept C2776235491 @default.
- W2063841770 hasConcept C2780192828 @default.
- W2063841770 hasConcept C2781406297 @default.
- W2063841770 hasConcept C71924100 @default.
- W2063841770 hasConcept C86803240 @default.
- W2063841770 hasConceptScore W2063841770C121608353 @default.
- W2063841770 hasConceptScore W2063841770C126322002 @default.
- W2063841770 hasConceptScore W2063841770C142724271 @default.
- W2063841770 hasConceptScore W2063841770C146357865 @default.
- W2063841770 hasConceptScore W2063841770C151730666 @default.
- W2063841770 hasConceptScore W2063841770C2775934546 @default.
- W2063841770 hasConceptScore W2063841770C2776235491 @default.
- W2063841770 hasConceptScore W2063841770C2780192828 @default.
- W2063841770 hasConceptScore W2063841770C2781406297 @default.
- W2063841770 hasConceptScore W2063841770C71924100 @default.
- W2063841770 hasConceptScore W2063841770C86803240 @default.
- W2063841770 hasIssue "5" @default.
- W2063841770 hasLocation W20638417701 @default.
- W2063841770 hasLocation W20638417702 @default.
- W2063841770 hasLocation W20638417703 @default.
- W2063841770 hasLocation W20638417704 @default.
- W2063841770 hasOpenAccess W2063841770 @default.
- W2063841770 hasPrimaryLocation W20638417701 @default.
- W2063841770 hasRelatedWork W1884231116 @default.
- W2063841770 hasRelatedWork W1979374145 @default.
- W2063841770 hasRelatedWork W2102167265 @default.
- W2063841770 hasRelatedWork W2148869351 @default.
- W2063841770 hasRelatedWork W2566665866 @default.
- W2063841770 hasRelatedWork W2888896143 @default.
- W2063841770 hasRelatedWork W2995116858 @default.
- W2063841770 hasRelatedWork W3015759778 @default.
- W2063841770 hasRelatedWork W4220839022 @default.
- W2063841770 hasRelatedWork W99274037 @default.